Stempeutics Research Private Limited is a leading stem cell company in India, focusing on Research, Therapeutics and Therapy in the field of regenerative medicine. With the aim to develop therapies to treat various diseases, we at Stempeutics undertake research to acquire knowledge and understanding of stem cells and their differentiation process.
Stempeutics is committed to help patients by delivering safe, effective and affordable stem cell therapies.
Stempeutics has started experimental stem cell therapies in Parkinson disease, motor neuron disease, spinal cord injury, scleroderma, DMD, End stage liver disease.
Stem cells are the master cells of the human body. They can divide to produce copies of themselves and many other types of cell. They are found in various parts of the human body at every stage of development from embryo to adult.
Because stem cells are so versatile, they could potentially be used to repair and replace damaged human tissue. The purpose of experimental stem cell therapy is to offer potential benefits of stem cells, which may be:
To slow down or stop further deterioration caused by the disease
To see if stem cells can reverse the effects of the disease
This procedure is considered experimental as it is being tested in clinical research studies, and is not yet available as a standard medical treatment.
The stem cells used in our experimental therapy are Mesenchymal stem cells, which are derived from your own bone marrow. These are multipotent stem cells that can transform into a variety of cell types, and thereby help in regeneration and repair of the diseased tissues.
Stempeutics is engaged in pioneering stem cells research that offers hope to millions to add life to their years, or shall we say - "Regenerating Hope".
BioNexus status
Stempeutics is the first international company in Malaysia to receive the BioNexus status. ICMR
Stempeutics, Bangalore, has been approved by Indian Council of Medical Research for Stem Cell Research activities.
Stempeutics has established a significant patent position in stem cell technology in India. The Company has committed to protect its intellectual property position and currently owns 6 Indian patents and has filed for international patents.
